IKONISYS
-
EUR
(-)
- 15 min delayed data - Euronext Paris
| Open: | - |
| Change: | - |
| Volume: | - |
| Low: | - |
| High: | - |
| High / Low range: | - |
| Type: | Stocks |
| Ticker: | ALIKO |
| ISIN: | FR00140048X2 |
IKONISYS news, videos and press releases
For more news please use our advanced search feature.
IKONISYS - More news...
IKONISYS - More news...
- 04/03/2025 - 06:00 Ikonisys SA: Hospitex International Launches Urine24, the First-Online Urinary Cytology Test Platform, Marking a Breakthrough in Early Bladder Cancer Diagnosis in Italy
- 03/10/2025 - 17:00 Ikonisys SA Wins Public Tender with F. Miulli Regional General Hospital for Pathological Anatomy
- 02/27/2025 - 18:17 Ikonisys Finalized a Capital Increase Through a Private Placement
- 02/05/2025 - 17:18 Ikonisys’ Subsidiary Hospitex Secures a Major UN-Funded Contract for Hospital IT and Networking Systems in Ethiopia
- 01/27/2025 - 07:00 Ikonisys Secures U.S. Patent for “Automated Fluorescence Microscopy Method to Determine the Efficacy of Cancer and Hyperplasia Treatments”
- 01/15/2025 - 06:30 Ikonisys: Hospitex Secures Major Public Tender for "Gaetano Martino" University Hospital in Messina
- 01/10/2025 - 07:10 Ikonisys finalized a capital increase through the offsetting of debt
- 12/31/2024 - 17:00 Ikonisys Finalized the Acquisition of Hospitex with the Issuance of 2M New Shares to ETH Scientific
- 12/04/2024 - 17:31 The Ikonisys Group Unveils its New Vision and Strategy Under the Brand “ALIKO SCIENTIFIC”
- 11/25/2024 - 17:00 Ikonisys Group Secures Major Public Contract for Ikoniscope20 Robotic Microscope in Italy
- 11/19/2024 - 07:00 Ikonisys Completed a Capital Increase Through a Private Placement
- 11/18/2024 - 06:30 Ikonisys Group enters Central America Market through a Partnership and Distribution Agreement with Green Med Panama
- 11/12/2024 - 17:48 Ikonisys Group Renews Agreement as European Authorized Representative and Importer for Novodiax’s CE IVD-Certified Real-Time Immunohistochemistry Technology in Oncological Diagnostics and Organ Transplant Safety
- 08/03/2023 - 16:37 Ikonisys Announces the Completion of New Financing via the Issuance of a €0.5m Private Note
- 07/31/2023 - 05:30 Ikonisys presents an update of its global activity in the context of its recent technological and commercial milestones
- 07/28/2023 - 05:30 Ikonisys Announces the Successful Deployment of the Commercial Strategy With the Second Sale of the Ikoniscope20max Solution
- 07/26/2023 - 16:17 Half-Yearly Report on the Ikonisys Liquidity Contract at 30/06/2023
- 06/30/2023 - 15:45 Ikonisys Announces the Results of Its Ordinary Annual and Extraordinary General Meeting of June 28, 2023
- 06/21/2023 - 16:57 Ikonisys Announces the First Sale of the Ikoniscope20max Solution
- 06/15/2023 - 06:00 Ikonisys Announces the Completion of a Private Placement to Accelerate Its Commercial Development
- 06/14/2023 - 16:33 Ikonisys SA: Terms and Conditions of Availability of Preparatory Documents for the General Meeting of June 28, 2023
- 04/29/2023 - 18:27 Ikonisys publishes its Full-Year Financial Results for 2022 and provides an update on its latest developments
- 01/30/2023 - 16:45 Ikonisys and Integrated Gulf Biosystems Group enter into Distribution Collaboration for Distribution of the Ikoniscope20 System in the Middle East Market
- 11/14/2022 - 17:53 Ikonisys Announces the Launch of Its Instrument for High-Volume Customers, the Ikoniscope20max
- 10/27/2022 - 15:45 Ikonisys Publishes Its 2022 Half-Year Financial Results and Reviews Its Operational Deployments
- 09/26/2022 - 16:00 Ikonisys Announces the Installation of the Ikoniscope20 Solution at a US Leading Urology Laboratory
- 09/13/2022 - 15:57 Ikonisys Announces the Start of a Distribution Collaboration with BioVendor Laboratory Medicine for Distribution of the Ikoniscope20 System in the Eastern European Market
- 07/26/2022 - 16:00 Ikonisys Reinforces Its Strategic Collaboration With Empire Genomics Following Excellent Results of Optimized Reagents in Detection of Bladder Cancer Cells
- 06/22/2022 - 16:36 Ikonisys Announces the First Sale of the Ikoniscope20 Solution Including the Newly Added Reagents to Comprehensive Urology
- 06/22/2022 - 16:14 Ikonisys Announces the First Sale of the Ikoniscope20 Solution Including the Newly Added Reagents to Comprehensive Urology
